SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corcept Therapeutics Incorporated (CORT) -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (2)6/23/2004 9:07:10 PM
From: mopgcw  Read Replies (1) | Respond to of 32
 
Corcept Therapeutics Rated `Market Perform' at Piper Jaffray
2004-06-01 07:03 (New York)

Princeton, New Jersey, June 1 (Bloomberg Data) -- Corcept Therapeutics
Inc. (CORT US) was rated new ``market perform'' in new coverage by analyst
Thomas Wei at Piper Jaffray & Co. The price target is $11.00 per share.